Training healthcare providers to promote PrEP for young women in the Deep South

PrEP Pro: Adapting a multi-component intervention to train and support providers to promote PrEP for adolescent girls and young women in the Deep South

NIH-funded research University of Alabama at Birmingham · NIH-10663866

This study is all about helping Black adolescent girls and young women at high risk for HIV get better access to a preventive medication called PrEP, by training healthcare providers to overcome challenges like stigma and lack of knowledge.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-10663866 on NIH RePORTER

What this research studies

This research focuses on improving the uptake of pre-exposure prophylaxis (PrEP) among Black adolescent girls and young women who are at high risk for HIV. It aims to address barriers that healthcare providers face in prescribing PrEP, such as stigma and lack of training. By adapting an evidence-based curriculum and creating a multi-component intervention, the project seeks to empower providers with the knowledge and tools necessary to effectively support young women in accessing PrEP. The intervention will specifically target Family Medicine trainees, who play a crucial role in adolescent healthcare.

Who could benefit from this research

Good fit: Ideal candidates for this research are Black adolescent girls and young women in the Deep South who are at high risk for HIV.

Not a fit: Patients who are not at risk for HIV or who do not identify as Black adolescent girls and young women may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly increase the number of young women who receive PrEP, thereby reducing their risk of HIV acquisition.

How similar studies have performed: Other research has shown success in similar interventions aimed at increasing PrEP uptake among high-risk populations, indicating a promising approach.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency SyndromeAcquired Immuno-Deficiency SyndromeAcquired Immunologic Deficiency SyndromeAcquired Immunodeficiency Syndrome
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.